When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement…read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma.
The Director, Supply Chain Strategy & Operations will join a lean team that enables the commercial supply of multiple products across the BridgeBio ecosystem of companies, with an immediate focus on the commercial supply of Attruby™/Beyonttra™, our recently FDA, EMA, and PMDA-approved product, and subsequent focus on other programs and geographies. This individual will ensure the support of an efficient, uninterrupted supply of medicine by developing strategies to improve our CMC/Supply Chain function, play an operational role in the implementation of new methods, and serve as a key interface between the CMC/Supply Chain team and partners across the business (e.g., Commercial, FP&A, Accounting, Legal, BD, Management).
This is a hybrid role and requires in-office collaboration 3x per week, or as needed, in our San Francisco, CA & Palo Alto, CA offices.
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Health & Wellbeing:
Skill Development & Career Paths:
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. To learn more about our story and company culture, visit us at https://bridgebio.com
Understand the required skills and qualifications, anticipate the questions you may be asked, and study well-prepared answers using our sample responses.
Director Q&A's